This enables safe and effective new therapeutics to advance more efficiently through the different stages of clinical trials 1,” said US FDA commissioner Scott Gottlieb, MD. “Modeling and simulation play a critical role in organizing diverse data sets and exploring alternate study designs. By subscribing, you agree to receive email related to Lab Manager content and products.
